A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a double blind, randomized, placebo controlled, single and multiple ascending dose study in healthy subjects. Safety evaluation will include (serious) adverse events, vital signs, body weight and lung function tests. Blood samples for Pharmacokinetics will also be drawn at specified timepoints.
Epistemonikos ID: 656ff643958fbd3fa03aa6639d915cfcf4a9e441
First added on: May 12, 2024